poisar

Stocks · News reference

Senti Biosciences Signs Agreement To Sell Assets Related To Its Gene-Circuit-Enabled Pipeline To Celadon For Up To $60M In Milestone Payments Over Seven Years

Jul 15, 2026, 11:33 AMBenzinga Newsdesk

Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) ("SBH" or the "Company") today announced a strategic transaction designed to sharpen its focus on next-generation controllable genetic medicines powered by

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SNTI
Source
benzinga
Observed
Jul 15, 2026, 11:33 AM
Checked
Jul 15, 2026, 11:33 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading